| 000 | 01671 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250517002625.0 | ||
| 264 | 0 | _c20160310 | |
| 008 | 201603s 0 0 eng d | ||
| 022 | _a1476-5381 | ||
| 024 | 7 |
_a10.1111/bph.13016 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aCerrato, F | |
| 245 | 0 | 0 |
_aClinically used selective oestrogen receptor modulators increase LDL receptor activity in primary human lymphocytes. _h[electronic resource] |
| 260 |
_bBritish journal of pharmacology _cMar 2015 |
||
| 300 |
_a1379-94 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aCells, Cultured |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 |
_aDown-Regulation _xdrug effects |
| 650 | 0 | 4 | _aHep G2 Cells |
| 650 | 0 | 4 |
_aHepatocytes _xdrug effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLipoproteins, LDL _xchemistry |
| 650 | 0 | 4 |
_aLovastatin _xchemistry |
| 650 | 0 | 4 |
_aLymphocytes _xcytology |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aRaloxifene Hydrochloride _xchemistry |
| 650 | 0 | 4 |
_aReceptors, LDL _xmetabolism |
| 650 | 0 | 4 |
_aSelective Estrogen Receptor Modulators _xchemistry |
| 650 | 0 | 4 | _aStructure-Activity Relationship |
| 650 | 0 | 4 |
_aTamoxifen _xchemistry |
| 650 | 0 | 4 |
_aToremifene _xchemistry |
| 700 | 1 | _aFernández-Suárez, M E | |
| 700 | 1 | _aAlonso, R | |
| 700 | 1 | _aAlonso, M | |
| 700 | 1 | _aVázquez, C | |
| 700 | 1 | _aPastor, O | |
| 700 | 1 | _aMata, P | |
| 700 | 1 | _aLasunción, M A | |
| 700 | 1 | _aGómez-Coronado, D | |
| 773 | 0 |
_tBritish journal of pharmacology _gvol. 172 _gno. 5 _gp. 1379-94 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/bph.13016 _zAvailable from publisher's website |
| 999 |
_c24352814 _d24352814 |
||